Tag:
pralatrexate
Latest Headlines
Latest Headlines
Allos shares plunge on blood cancer trial results
Slightly more than one out of every four patients taking an experimental blood cancer drug--pralatrexate--developed by Allos Therapeutics experienced a complete or partial response in a pivotal Phase
